On the inhibiting effect of sulfinpyrazone on platelets. 1979

M Cortellaro, and E E Polli

UI MeSH Term Description Entries
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone

Related Publications

M Cortellaro, and E E Polli
February 1981, Schweizerische medizinische Wochenschrift,
M Cortellaro, and E E Polli
January 1977, Revista clinica espanola,
M Cortellaro, and E E Polli
July 1981, Schweizerische medizinische Wochenschrift,
M Cortellaro, and E E Polli
January 1993, Cardiology,
M Cortellaro, and E E Polli
January 1983, Thrombosis research. Supplement,
M Cortellaro, and E E Polli
April 1964, The Medical journal of Australia,
M Cortellaro, and E E Polli
January 1985, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M Cortellaro, and E E Polli
January 1981, Fortschritte der Medizin,
M Cortellaro, and E E Polli
March 1979, Lancet (London, England),
M Cortellaro, and E E Polli
June 1982, Canadian journal of physiology and pharmacology,
Copied contents to your clipboard!